Biomea Fusion, Inc. (BMEA)
0.6001
+0.02
(+2.58%)
USD |
NASDAQ |
Oct 23, 16:00
0.6117
+0.01
(+1.93%)
Pre-Market: 20:00
Biomea Fusion Price to Book Value : 3.584 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.584 |
| October 22, 2026 | 3.494 |
| October 21, 2026 | 4.122 |
| October 20, 2026 | 4.393 |
| October 19, 2026 | 4.990 |
| October 16, 2026 | 5.189 |
| October 15, 2026 | 4.995 |
| October 14, 2026 | 4.981 |
| October 13, 2026 | 7.525 |
| October 12, 2026 | 8.122 |
| October 09, 2026 | 8.481 |
| October 08, 2026 | 8.182 |
| October 07, 2026 | 7.883 |
| October 06, 2026 | 7.465 |
| October 05, 2026 | 7.764 |
| October 02, 2026 | 7.585 |
| October 01, 2026 | 7.764 |
| September 30, 2026 | 7.943 |
| September 29, 2026 | 7.525 |
| September 28, 2026 | 7.704 |
| September 25, 2026 | 7.883 |
| September 24, 2026 | 8.899 |
| September 23, 2026 | 8.600 |
| September 22, 2026 | 10.15 |
| September 21, 2026 | 10.21 |
| Date | Value |
|---|---|
| September 18, 2026 | 10.93 |
| September 17, 2026 | 10.69 |
| September 16, 2026 | 10.39 |
| September 15, 2026 | 10.75 |
| September 14, 2026 | 10.63 |
| September 11, 2026 | 10.39 |
| September 10, 2026 | 10.15 |
| September 09, 2026 | 11.02 |
| September 08, 2026 | 11.53 |
| September 04, 2026 | 12.12 |
| September 03, 2026 | 11.41 |
| September 02, 2026 | 11.56 |
| September 01, 2026 | 10.75 |
| August 31, 2026 | 10.03 |
| August 28, 2026 | 10.33 |
| August 27, 2026 | 10.03 |
| August 26, 2026 | 10.21 |
| August 25, 2026 | 10.33 |
| August 24, 2026 | 9.496 |
| August 21, 2026 | 8.182 |
| August 20, 2026 | 8.122 |
| August 19, 2026 | 8.302 |
| August 18, 2026 | 8.063 |
| August 17, 2026 | 8.063 |
| August 14, 2026 | 7.883 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| REGENXBIO, Inc. | 5.042 |
| Compass Therapeutics, Inc. | 0.8253 |
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
Price to Book Value Related Metrics
| Price | 0.6001 |
| Earnings Yield | -82.84% |
| Market Cap | 43.50M |